Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
News
Blood Cancer United Welcomes Court Ruling that Protects Medicaid Access for Patients with Blood Cancer & Other Medical Conditions
Blood Cancer United welcomes a federal court ruling that rejects efforts to weaken Medicaid protections for people with cancer and other serious medic…
News
Blood Cancer United Invests $2.5 Million in Health Services Research to Improve Clinical Trial Participation
Blood Cancer United has awarded $2.5 million to a research team led by Melissa Beauchemin, Ph.D., Assistant Professor at Columbia University School of…
News
FDA Approves New Treatment Option for Select Patients with Previously Untreated CLL, SLL
Blood Cancer United was at the forefront of funding research that advanced the understanding of the role of the BTK protein in the proliferation of se…
News
Inaugural Breakthrough Voice & Breakthrough Rising Leader Awards Presented at First-Ever Night of Champions
Blood Cancer United kicked off the reimagined Breakthroughs Summit with its first-ever Night of Champions, presenting its inaugural Breakthrough Voice…
News
Blood Cancer Survival Has Improved Substantially, but Outcomes Vary Widely by Disease; Males Account for Nearly 56% of Diagnoses
New data provide the latest national and state-level statistics on blood cancer incidence, prevalence, survival and mortality.
News
Blood Cancer United and Edward P. Evans Foundation Collaboration Advances Research for Patients With Myelodysplastic Syndromes
The collaboration includes a $2.5 million investment from both Blood Cancer United and the Edward P. Evans Foundation to support a five-year multidisc…
News
Blood Cancer United Rings Nasdaq Closing Bell to Celebrate More Time for Patients
Blood Cancer United® rang the Nasdaq Stock Market Closing Bell today in Times Square to culminate Blood Cancer Awareness Month and celebrate a powerfu…
News
Velo Palmetto Joins Team In Training
Blood Cancer United® is announcing the next chapter in the evolution of its athletic fundraising programs: Velo Palmetto will become the first event p…
News
Nearly $7 Million in New Funding Accelerates Hairy Cell Leukemia Research
The Hairy Cell Leukemia Foundation and Blood Cancer United have extended their partnership to accelerate a cure and improve quality of life for patien…
News
Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program
Donation marks a new phase for Blood Cancer United’s venture philanthropy program, with returns reinvested to support future therapies
News
FDA Approves Treatment for Rare Blood Cancer Essential Thrombocythemia
The U.S. Food and Drug Administration (FDA) has approved ropeginterferon alfa-2b-njft (BESREMi®) for adults with essential thrombocythemia; the first …
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
